Interviews

Explore how cyclodextrins in advanced biopharma delivery enhance drug stability, bioavailability, patient access and new formats for innovative treatments.

You’ve had a diverse career across biotech, pharma, consulting, and public health. What experiences have shaped your approach to data science and strategic consulting? I believe my training as a mathematical modeler, statistician and data scientist has given me a...

Q1: How can pharmaceutical laboratories quantify the financial impact when it comes to underutilized equipment in today’s constrained economic environment? What are the steps taken by Elemental Machines in this regard? A: Underutilized equipment is one of those hidden costs...

Dr. Oliver Okle is a product and service manager at Vetter The global CDMO market is projected to more than double from $161 billion in 2023 to $322.76 billion by 20331. This is only a portion of the rapid growth...

Jason Shuris is the Chief Business Officer at Indero, formerly known as Innovaderm. Jason has more than 25 years of experience in the life sciences and CRO (contract research organization) sectors. His vast experience in clinical research and strategic...

datma is a leading provider of federated Real-World Data platforms and related tools for data analysis and visualization. datma’s mission is to empower healthcare organizations, including providers, clinicians, and researchers, to optimize their data assets, driving innovation and improving...

In this exclusive interview, World Pharma Today sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the healthcare and pharmaceutical sectors. The conversation explores their insights...